Current Value
$13.421 Year Return
Current Value
$13.421 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUSA | -0.14% | $8.56M | -56.67% | 0.00% |
VZ | -0.21% | $184.42B | +9.98% | 6.26% |
RILY | 0.22% | $92.41M | -86.83% | 0.00% |
ARLP | -0.33% | $3.33B | +8.48% | 10.85% |
XEL | 0.38% | $39.36B | +24.61% | 3.23% |
MO | 0.41% | $100.92B | +30.61% | 6.82% |
OXBR | 0.45% | $12.50M | -25.00% | 0.00% |
CPSH | -0.46% | $39.37M | +58.02% | 0.00% |
IMNN | -0.51% | $29.12M | +36.07% | 0.00% |
DOGZ | 0.57% | $324.76M | +68.38% | 0.00% |
NEXA | -0.58% | $650.28M | -37.13% | 0.00% |
KNOP | -0.65% | $226.19M | -7.37% | 1.57% |
CNC | 0.76% | $27.50B | -18.37% | 0.00% |
PEG | 0.77% | $40.32B | +10.64% | 3.04% |
TPB | 0.90% | $1.34B | +138.43% | 0.39% |
FDP | 0.92% | $1.56B | +45.08% | 3.35% |
NGL | -0.96% | $549.17M | -22.39% | 0.00% |
ACI | 0.98% | $12.25B | +5.30% | 2.53% |
LTM | -1.04% | $12.15B | -96.20% | 2.54% |
T | 1.08% | $203.92B | +60.93% | 3.93% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -28.43% | $153.01M | 0.85% |
BTAL | -25.82% | $298.87M | 1.43% |
TAIL | -23.58% | $107.77M | 0.59% |
TPMN | -9.52% | $30.67M | 0.65% |
SHYM | -9.49% | $324.05M | 0.35% |
ULST | -6.89% | $663.99M | 0.2% |
CLIP | -6.23% | $1.50B | 0.07% |
SMB | -5.49% | $272.68M | 0.07% |
USDU | -5.41% | $165.88M | 0.5% |
UUP | -5.27% | $209.44M | 0.77% |
CTA | -5.23% | $1.09B | 0.76% |
STOT | -5.22% | $235.94M | 0.45% |
LMBS | -4.42% | $5.03B | 0.64% |
IVOL | -4.22% | $358.39M | 1.02% |
VRIG | -4.07% | $1.20B | 0.3% |
SHYD | -3.81% | $322.63M | 0.35% |
UNG | -3.13% | $372.51M | 1.06% |
TFLO | -3.02% | $6.97B | 0.15% |
CANE | -2.74% | $10.08M | 0.29% |
SPTS | -2.64% | $5.78B | 0.03% |
Yahoo
CAMBRIDGE, Mass. & SALISBURY, England, June 05, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of six scientific abstracts at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 taking place in Glasgow, United Kingdom from June 13–16, 2025.
Yahoo
CAMBRIDGE, Mass. & SALISBURY, England, June 03, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista’s board of directors granted five newly-hired employees inducement options to purchase an aggregate of 50,000 shares of KalVista common stock on June 1, 2025 as inducements material to each employee entering into employment with KalVista. The options have an exercise price that is equal to the closing price of KalVista common stock on th
Yahoo
CAMBRIDGE, Mass. & SALISBURY, England, June 02, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new sebetralstat findings related to time to end of progression of hereditary angioedema (HAE) attacks, and the effectiveness of treatment of attacks considered the most debilitating by patients, mucosal attacks, and attacks that have progressed in severity after a treatment delay. These data were presented at two congresses taking place concurrently: the 14th C1-inhibitor Deficien
Yahoo
CAMBRIDGE, Mass. & SALISBURY, England, May 29, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Company will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 8:45 a.m. ET.
Yahoo
CAMBRIDGE, Mass. & SALISBURY, England, May 22, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that it will present new sebetralstat data at two upcoming congresses taking place concurrently from May 29–June 1, 2025: the 14th C1-inhibitor Deficiency & Angioedema Workshop in Budapest, Hungary, and the Eastern Allergy Conference (EAC) in Palm Beach, Florida. The presentations will include new findings on the potential of sebetralstat to rapidly relieve symptoms and halt progres
Finnhub
Corporate Overview May 2025 ...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IDYA | 46.02% | $1.92B | -44.38% | 0.00% |
ATXS | 44.48% | $326.75M | -37.61% | 0.00% |
IRON | 43.29% | $1.76B | +30.91% | 0.00% |
CRSP | 42.75% | $3.59B | -35.96% | 0.00% |
KYMR | 42.44% | $3.15B | +39.86% | 0.00% |
FATE | 41.87% | $177.68M | -58.89% | 0.00% |
IMNM | 41.13% | $825.75M | -40.69% | 0.00% |
YMAB | 40.26% | $223.31M | -58.98% | 0.00% |
AUTL | 39.99% | $596.16M | -48.39% | 0.00% |
TWST | 39.95% | $2.11B | -32.97% | 0.00% |
KRYS | 39.93% | $4.03B | -23.27% | 0.00% |
OCUL | 39.89% | $1.41B | +78.90% | 0.00% |
ARWR | 39.78% | $2.31B | -35.04% | 0.00% |
CRNX | 39.63% | $3.03B | -32.34% | 0.00% |
DNLI | 39.42% | $2.21B | -29.48% | 0.00% |
EYPT | 39.25% | $606.23M | -5.47% | 0.00% |
CELC | 39.02% | $472.95M | -16.73% | 0.00% |
RYTM | 38.79% | $4.13B | +53.39% | 0.00% |
APLS | 38.13% | $2.42B | -54.66% | 0.00% |
ESTA | 38.08% | $1.11B | -18.74% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -13.65% | $5.10K | -99.92% | 0.00% |
CBOE | -12.08% | $23.34B | +31.58% | 1.12% |
ACHC | -10.36% | $2.10B | -66.42% | 0.00% |
LITB | -9.33% | $21.77M | -74.81% | 0.00% |
UUU | -9.24% | $7.36M | +96.30% | 0.00% |
K | -7.60% | $28.31B | +38.89% | 2.82% |
VSTA | -7.43% | $331.23M | +31.32% | 0.00% |
ZCMD | -5.51% | $26.26M | -13.33% | 0.00% |
STG | -4.87% | $32.24M | -0.16% | 0.00% |
FATBB | -4.03% | $43.80M | -23.18% | 10.33% |
PRPO | -3.68% | $16.74M | +87.63% | 0.00% |
CCRN | -3.50% | $431.43M | -9.12% | 0.00% |
NEUE | -3.46% | $60.80M | +26.11% | 0.00% |
ED | -3.30% | $36.95B | +12.52% | 3.26% |
ETR | -3.18% | $35.39B | +53.04% | 4.26% |
BTCT | -2.85% | $21.81M | +56.22% | 0.00% |
PSQH | -2.73% | $107.02M | -32.86% | 0.00% |
RLX | -2.63% | $1.98B | +19.13% | 0.46% |
CYCN | -2.59% | $9.66M | +32.60% | 0.00% |
CME | -1.52% | $97.17B | +37.77% | 3.95% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 53.77% | $4.89B | 0.35% |
PTH | 50.35% | $104.10M | 0.6% |
IBB | 48.99% | $5.23B | 0.45% |
GNOM | 48.52% | $44.34M | 0.5% |
ARKG | 46.76% | $980.60M | 0.75% |
PBE | 45.78% | $229.19M | 0.58% |
IWC | 44.24% | $813.58M | 0.6% |
XPH | 43.57% | $153.36M | 0.35% |
IWO | 43.44% | $11.46B | 0.24% |
KJUL | 41.97% | $119.80M | 0.79% |
BBH | 41.90% | $334.99M | 0.35% |
IWM | 41.72% | $62.41B | 0.19% |
VTWO | 41.60% | $12.36B | 0.07% |
PINK | 41.38% | $131.18M | 0.5% |
FBT | 40.12% | $1.05B | 0.54% |
KOMP | 39.38% | $2.25B | 0.2% |
KJAN | 39.09% | $288.29M | 0.79% |
SCHA | 38.88% | $17.13B | 0.04% |
IWMY | 38.78% | $109.69M | 1.02% |
IJT | 38.73% | $6.07B | 0.18% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
KRBN | -0.19% | $161.71M | 0.85% |
AGZD | 0.25% | $110.64M | 0.23% |
IBD | 0.30% | $381.73M | 0.43% |
IBTG | 0.33% | $1.94B | 0.07% |
TBIL | -0.47% | $5.91B | 0.15% |
UGA | 0.61% | $72.57M | 0.97% |
CORN | 0.75% | $47.42M | 0.2% |
JMST | 0.84% | $3.84B | 0.18% |
PALL | 0.96% | $446.95M | 0.6% |
IBTH | 0.97% | $1.57B | 0.07% |
XONE | 1.07% | $634.70M | 0.03% |
GOVZ | 1.18% | $260.33M | 0.1% |
BUXX | 1.22% | $304.62M | 0.25% |
UTWO | 1.27% | $374.41M | 0.15% |
FMHI | 1.33% | $751.88M | 0.7% |
MEAR | 1.38% | $1.08B | 0.25% |
USTB | 1.39% | $1.24B | 0.35% |
SCHO | 1.43% | $10.93B | 0.03% |
FTSD | -1.45% | $228.13M | 0.25% |
STXT | 1.58% | $127.50M | 0.49% |